Differential malware forensics

Athina Provataki,Vasilios Katos

DOI: https://doi.org/10.1016/j.diin.2013.08.006

2013-12-01

Abstract:

What problem does this paper attempt to address?

Correlation of Stress Hyperglycemia after Ischemic Stroke with Early Vascular Cognitive Impairment

Yi Dong Zhou,Huai Wu Yuan,Ren Jie Ji,Ben Yan Luo

DOI: https://doi.org/10.3881/j.issn.1000-503x.2017.06.003

2017-01-01

Abstract:Objective To investigate the influence and forecast value of stress hyperglycemia on the early vascular cognitive impairment (VCI) in stroke patients.Methods Totally 422 patients with acute non-diabetic stroke were divided into three groups according to the fasting plasma glucose level:the euglycemia group (<6.1 mmol/L),the mild stress hyperglycemia group (6.1-7.0 mmol/L),and the severe stress hyperglycemia group (≥7.0 mmol/L).Mini-mental state examination,Alzheimer's disease rating scale cognitive subscale,and clinical dementia rating scale were used to evaluate early cognition in post-stroke patients,and patients were divided into three groups accordingly:normal cognitive function group,mild VCI group,and vascular dementia group.Correlation analysis was carried out on the level of stress hyperglycemia and the degree of VCI.Results Of these 422 patients,stress hyperglycemia was identified in 62 cases (14.7%).The risk of stress hyperglycemia was higher in patients with a high degree of education [(8.39±3.85)years vs.(6.62±4.39)years,P=0.037)] or a history of cardiovascular disease (45.2% vs.18.3%,P=0.001).VCI was detected in 270 patients (64.0%).Age,sex,smoking,National Institute of Health Stroke Scale score,Hamilton Depression Rating Scale score,stress hyperglycemia,and history of cardiovascular disease were related with early VCI after non-diabetic ischemic stroke (P<0.05).Multivariate Logistic regression analysis showed that stress hyperglycemia was an independent risk factor for VCI in patients with non-diabetic ischemic stroke (OR=3.086,95% CI=1.065-8.929).The risks of cognitive impairment in the mild stress hyperglycemia group and the severe stress hyperglycemia group were higher than that of the euglycemia group,while it was also higher in the severe stress hyperglycemia group than in the mild stress hyperglycemia group (61.11% vs.75.00% vs.90.91%).Stress hyperglycemia was positively correlated with the high risk of early cognitive impairment in stroke patients (rs=0.185,P=0.007).Conclusion There is a significant correlation between stress hyperglycemia and early VCI after ischemic stroke.
On the α(u, v)-symmetric implicational method for R- and (S, N)-implications

Yiming Tang,W. Pedrycz

DOI: https://doi.org/10.1016/j.ijar.2017.10.009

IF: 4.452

International Journal of Approximate Reasoning

Abstract:
Management of Hyperglycemia in Acute Ischemic Stroke

Lauren Baker,Rattan Juneja,Askiel Bruno

DOI: https://doi.org/10.1007/s11940-011-0143-8

IF: 2

2011-08-23

Current Treatment Options in Neurology

Abstract:Opinion statementThere is considerable clinical evidence that hyperglycemia at the onset of acute ischemic stroke may negatively impact not only acute morbidity but also brain recovery. Establishing hyperglycemia treatment protocols is challenging, given the variation among patients and acute stroke care settings. Relatively few randomized trials have examined glycemic control protocols in this population, and there is not yet any clear evidence that “correcting” hyperglycemia in patients with acute stroke leads to better functional outcomes. Intensification of glucose regimens, using lower glucose targets, leads to more hypoglycemic events, but the immediate and long-term impact of these events on the acutely ischemic brain is unknown. It is reasonable to treat patients with acute ischemic stroke according to the American Diabetes Association inpatient glycemic control guidelines, initiating therapy to achieve glucose targets of 140 to 180 mg/dL if fasting glucose is greater than 140 mg/dL or random glucose is consistently higher than 180 mg/dL. Lower glucose targets (<140 mg/dL) may be appropriate for patients with well-controlled diabetes and those with stress hyperglycemia who were not known to be diabetic before admission, but glucose levels less than 80 mg/dL should be avoided. Patients who present with extreme or persistent hyperglycemia, are critically ill, or who are treated with thrombolytic therapy should be started on an established and standardized intravenous insulin protocol to improve blood glucose control for at least the first 24 to 48 h of hospitalization. They should then be transitioned to a subcutaneous insulin regimen that includes basal long-acting insulin along with correction rapid-acting insulin for glucose that is out of range. Prandial (meal) insulin should be added for patients who are eating; this would preferably be a rapid-acting insulin analogue that can be administered immediately before or after the meal. Caution and close glucose monitoring are necessary, especially for patients prone to hypoglycemia, such as those with type 1 diabetes mellitus or hepatic or renal impairment, or those on complicated feeding regimens.

clinical neurology
[Hyperglycemia: a predictor of poor prognosis in acute stroke]

M Mazighi,P Amarenco

Abstract:Hyperglycemia is common and involves up to 50% of the acute stroke patients. Several clinical studies have revealed that hyperglycemia is associated with a poor outcome in terms of mortality and neurological recovery. The results obtained from experimental studies have shown that hyperglycemia exacerbates the ischemic lesions and is associated with an increase of the edema and size of the infarct, as well as a decrease in the cerebral blood flow. In contradiction with animal models no increase in hemorrhagic transformation of the brain infarct after reperfusion is observed among patients with hyperglycemia, unless they are treated with rt-PA. Elevated plasma glucose levels (glycemia > 8 mmol/L) predict poor prognosis, irrespective of age, severity, or stroke sub-type. The benefit to treat a glycemia >=11 mmol/l has been established in terms of mortality for patients with myocardial infarction. Although the clinical benefit of plasma glucose lowering therapy remains unknown regarding acute stroke, based on current evidence, we recommend to treat moderate to mild hyperglycemia with glucose potassium insulin infusions.
Persistent Hyperglycemia is a Useful Glycemic Pattern to Predict Stroke Mortality: a Systematic Review and Meta-Analysis

Duanlu Hou,Ping Zhong,Xiaofei Ye,Danhong Wu

DOI: https://doi.org/10.1186/s12883-021-02512-1

2021-01-01

BMC Neurology

Abstract:Abstract Background Glycemic patterns have been reported to be prognostic factors for stroke; however, this remains to be further evaluated. This meta-analysis aimed to evaluate the usefulness of glycemic patterns such as persistent hyperglycemia (PH) including short duration and long duration PH (SPH; LPH), admission hyperglycemia (AH), short-duration hyperglycemia (SH), and persistent normoglycemia (PN) in predicting stroke prognosis using published results. Methods Major scientific databases including but are not limited to PubMed, EMBASE, Web of Science, Ovid, CNKI (Chinese National Knowledge Infrastructure), and Clinicaltrials.gov were searched till 1st March 2021 for clinical trials on the correlation between glycemic patterns and stroke outcomes. The primary outcome was defined as short-term (1- or 3-month) post-stroke mortality, and the secondary outcome was post-stroke hemorrhage at 6 months. Results Ten studies involving 3584 individuals were included in the final analysis. In subgroup analyses, PH patients with no history of diabetes had increased post-stroke mortality (odds ratio [OR]: 4.80, 95% CI: 3.06–7.54) than patients with no PH; and patients with glucose levels > 140 mg/dl had greater mortality (OR: 5.12, 95% CI: 3.21–8.18) than those with glucose levels < 140 mg/dl; compared with AH patients, PH patients had increased short-term mortality (OR: 0.31, 95% CI: 0.16–0.60). In the prediction of stroke mortality among patients without diabetes, SPH (OR: 0.28, 95%CI: 0.12–0.69) seemed to be more related to increased mortality than LPH (OR: 0.35, 95% CI: 0.14–-0.90). Conclusions PH, especially SPH, could predict increased post-stroke mortality in non-diabetic patients. The rank of individual glycemic patterns in predicting stroke mortality in non-diabetic patients was SPH > LPH > AH > PN.
High f/sub T/ 0.05/spl mu/m In/sub 0.52/AlAs/In/sub 0.53/GaAs HEMT's with strained 5 nm InAs sub-channel on InP substrate

Kim， Dae-Hyun,Noh Hun-Hee,Lee Kang-Min,Jaehak Lee,W. Feng,Xiaogang Xie,Q. Du,Jian Jiang,Seo Kwang-Seok

DOI: https://doi.org/10.1109/ICIPRM.2004.1442782

Abstract:An In/sub 0.52/AlAs/In/sub 0.53/GaAs HEMT with 5 nm InAs-inserted-channel into the In/sub 0.53/GaAs channel was fabricated using 0.05 /spl mu/m conventional T-shaped gate technology. The measured maximum transconductance (G/sub m,max/) is above 1 S/mm even at a lower drain voltage of 0.7 V and current gain cutoff frequency (f/sub T/) is 409 GHz. This excellent performance is attributed to the combination of the suppression of short-channel effect and the superior transport in 5 nm InAs-inserted-channel design concept. Higher f/sub T/ above 500 GHz is to be expected using the InAs-inserted-channel scheme, if reducing L/sub g/ down to sub-0.05/spl mu/m range.
Abstract WP3: Serum Glucose Fluctuations is an Independent Predictor of Adverse Outcomes in Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment

Saqib A Chaudhry,Hamza Khan,Akif Ali,Ashley McHugh,Maham Laleka,Mohammad Rauf A Chaudhry,Muhammad Taimoor Khan,Abdullah Zaki,Pouya Tahsili Fahadan,Laith Altaweel,Adnan Qureshi

DOI: https://doi.org/10.1161/str.55.suppl_1.wp3

IF: 10.17

2024-02-03

Stroke

Abstract:Stroke, Volume 55, Issue Suppl_1, Page AWP3-AWP3, February 1, 2024. Background:Acute hyperglycemia may increase the rate of death or disability among acute ischemic stroke patients undergoing endovascular procedures.Objective:To explore the association between serum glucose fluctuation on post treatment symptomatic intracranial hemorrhage (sICH) and mortality.Methods:We analyzed consecutive acute ischemic stroke patients who underwent endovascular treatment over 30 months at a comprehensive stroke center. Serum glucose levels within the initial 24 hours were used to calculate the mean and standard deviation (SD). Patients were grouped by the standard deviation [SD] of the mean value of serum glucose, whether above or below 25%. Outcomes included sICH, and inpatient mortality, adjusted for confounders which included age, gender, baseline NIHSS, perfusion grade (TICI) intravenous thrombolysis, history of diabetes and HBA1c.Results:A total of 224 patients (mean age was 68.7 years (±14.3); 44.2% were women) underwent endovascular treatment. The proportion of sICH (16.7% vs. 3.28%; p=0.0006) and inpatient mortality (18.6% vs. 7.4%; p=0.0112) were higher in patients with SD exceeding 25. After adjusting for potential confounders, serum glucose SD above 25 was significantly associated with increased rate of sICH (odds ratio [OR] 5.2; 95% confidence interval [CI] 1.5-18.5; p=0.0112) and inpatient mortality (OR 3.5; 95% CI 1.3-9.8; p=0.0154).Conclusion:Serum glucose fluctuations within first 24 hours maybe be therapeutic target due to its association with increased risks of sICH and inpatient mortality following endovascular treatment in acute ischemic stroke.

peripheral vascular disease,clinical neurology
Study on the Prognostic Effect of Hyperglycemia in Diabetic and Non-diabetic Patients Treated with Mechanical Thrombectomy

Ling WANG,Yong-Jie BAI,Wen-Jie ZI,Ge-Lin XU

DOI: https://doi.org/10.3969/j.issn.1673-5765.2018.04.004

2018-01-01

Abstract:Objective To investigate the prognostic value of hyperglycemia between diabetic and non-diabetic patients with acute ischemic stroke who received anterior circulation mechanical thrombectomy. Methods Patients included in this analysis were those who were enrolled in Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke Registry (ACTUAL) study and whose glucose level were >8.6 mmol/L. Patients were divided into diabetes and non-diabetes group according to the diagnosis based on diabetic history and admission glycosylated hemoglobin (HbAlc). The poor functional outcomes were defined as modified Rankin Scale (mRS) score 3-6 at 90 d after onset. Results A total of 160 patients whose glucose level were >8.6 mmol/L were included in this study, among which, 82 (51.2%) patients were diabetes and 78 (48.8%) patients were non-diabetes. A total of 114 (71.3%) patients had poor functional outcomes. Non-diabetic patients were more likely to reach poor functional outcomes(83.3% vs 59.8%,P=0.001).After adjusted for confounders including arthrosclerosis cardiac artery disease, hypertension, percentage of lymphocytes in neutrophils, National Institutes Of Health Stroke Scale (NIHSS) score, pucture-blood revascularization and blood glucose on admission, the multivariable logistic regression analysis showed that non-diabetes hyperglycemia still had a high risk of poor functional outcomes than diabetes [odds ratio (OR)=4.2, 95% confidence interval (CI) 1.52-11.56, P=0.006]. Conclusion The deleterious influence of hyperglycemia is more prominent in non-diabetic patients after received mechanical thrombectomy.
Cell type‐specific epigenome profiling using affinity‐purified nuclei

Z. Chitikova,F. Steiner

DOI: https://doi.org/10.1002/dvg.22919

2016-04-01

genesis

Abstract:The development of a multicellular organism from a single zygote depends on the differentiation of progenitor cells to specialized cell types. The differentiation of these cell types is associated with changes in gene expression and the underlying chromatin landscape. To understand how these processes are regulated, it is desirable to understand how the chromatin features that constitute the epigenome differ between cell types at any given time during development. INTACT, a method for the cell type‐specific purification of nuclei that can be used for the isolation of both RNA and chromatin, has emerged as a powerful tool to simultaneously study gene expression and chromatin profiles specifically in cell types of interest. In this review, we focus on the application of INTACT to different model organisms and discuss its potential for profiling cell types in their developmental context. genesis, 2016. © 2016 Wiley Periodicals, Inc. genesis 54:160–169, 2016. © 2016 Wiley Periodicals, Inc.
Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial

Navpreet K Bains,Wei Huang,Brandi R French,Farhan Siddiq,Camilo R Gomez,Adnan I Qureshi

DOI: https://doi.org/10.1136/neurintsurg-2021-018485

IF: 4.8

2022-04-12

Journal of NeuroInterventional Surgery

Abstract:Background Hyperglycemia has been associated with poor outcomes in acute ischemic stroke patients undergoing endovascular treatment. We analyzed the effect of intensive glucose control on death and disability rates in patients with acute ischemic stroke undergoing endovascular treatment. Methods We analyzed the effect of intensive (serum glucose <110 mg/dL) glucose treatment (compared with standard treatment, serum glucose <180 mg/dL) in patients who received endovascular treatment in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. We further analyzed the effect of area under the curve (AUC) of serum glucose, proportion of the time blood glucose was <140 mg/dL, and glucose variability defined as the glucose range during 72 hours. The primary outcomes were neurological deterioration within 72 hours and outcome at 90 days. Results A total of 146 patients (mean age 68.1±13.9 years, 50.7% men) underwent endovascular treatment for acute ischemic stroke; 72 and 74 patients were randomized to intensive and standard treatments, respectively. The rates of death (20.3% and 22.2%), favorable 90-day primary outcome (17.6% and 19.4%), and serious adverse events (41.9% and 56.98%) were similar between the two groups. The AUC of serum glucose was not associated with death within 90 days (OR 1, 95% CI 1 to 1) or favorable outcome at 90 days (OR 1, 95% CI 1 to 1). Glucose variability was not associated with death or favorable outcome at 90 days. Conclusion We did not identify any beneficial effect of intensive glucose reduction on rates of death or favorable outcomes at 90 days among acute ischemic stroke patients undergoing endovascular treatment.

surgery,neuroimaging
[Diagnostics in clinically occult, radiologically suspect breast lesions more often surgery than needle diagnostics with image monitoring].

R. Pijnappel,P. Peeters,I. B. Borel Rinkes,J. Peterse,R. Holland,W. Mali

2001-04-07

Abstract:OBJECTIVE To inventory the diagnostic methods used in patients with clinically occult, radiologically suspect breast lesions. DESIGN Enquiry. METHOD The departments of radiology of all Dutch hospitals were sent a list in January 2000 containing questions concerning the number of thread localizations in 1999 and the use of cytological or histological needle diagnostics with image monitoring prior to surgical intervention in clinically occult, radiologically suspect breast lesions. Of the 120 questionnaires mailed, 74 (62%) were completed and returned by clinics throughout the country. RESULTS Fifty-one of the 74 hospitals (69%) had prior to operation carried out histological or cytological examinations and in these 51 hospitals this was done in 1743 of the 2857 lesions (61%): fine-needle aspiration cytology was performed in 1046 (/1743 = 60%; /4140 lesions in all 74 hospitals = 25%) and/or histological needle biopsy in 784 (45%; /4140 = 19%). CONCLUSION In less than half of all non-palpable breast abnormalities non-surgical methods of diagnosis are used, histological needle biopsy less often than fine needle aspiration cytology.
Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients

Rahul D Barmanray,Mervyn Kyi,Leon J Worth,Peter G Colman,Leonid Churilov,Timothy N Fazio,Gerry Rayman,Vicky Gonzalez,Candice Hall,Spiros Fourlanos

DOI: https://doi.org/10.1210/clinem/dgae051

2024-01-27

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Context Hyperglycemia in hospital inpatients without pre-existing diabetes is associated with increased mortality. However, the independent contribution of hyperglycemia to health care–associated infection (HAI), acute kidney injury (AKI), and stroke is unclear. Objective To investigate the relationship between hyperglycemia and adverse clinical outcomes in hospital for patients with and without diabetes. Methods Diabetes IN-hospital: Glucose and Outcomes (DINGO) was a 26-week (October 2019-March 2020) prospective cohort study. Clinical and glucose data were collected up to the 14th day of admission. Primary stratification was by hyperglycemia, defined as ≥2 random capillary blood glucose (BG) measurements ≥11.1 mmol/L (≥200 mg/dL). Propensity weighting for 9 clinical characteristics was performed to allow interrogation of causality. To maintain the positivity assumption, patients with HbA1c >12.0% were excluded and prehospital treatment not adjusted for. The setting was the Royal Melbourne Hospital, a quaternary referral hospital in Melbourne, Australia. Admissions with at least 2 capillary glucose values and length of stay >24 hours were eligible, with half randomly sampled. Outcome measures were HAI, AKI, stroke, and mortality. Results Of 2558 included admissions, 1147 (45%) experienced hyperglycemia in hospital. Following propensity-weighting and adjustment, hyperglycemia in hospital was found to, independently of 9 covariables, contribute an increased risk of in-hospital HAI (130 [11.3%] vs 100 [7.1%], adjusted odds ratio [aOR] 1.03, 95% CI 1.01-1.05, P = .003), AKI (120 [10.5%] vs 59 [4.2%], aOR 1.07, 95% CI 1.05-1.09, P < .001), and stroke (10 [0.9%] vs 1 [0.1%], aOR 1.05, 95% CI 1.04-1.06, P < .001). Conclusion In hospital inpatients (HbA1c ≤12.0%), irrespective of diabetes status and prehospital glycemia, hyperglycemia increases the risk of in-hospital HAI, AKI, and stroke compared with those not experiencing hyperglycemia.

endocrinology & metabolism
Abstract WMP3: Hyperglycemic Control In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: Post-hoc Analysis Of Stroke Hyperglycemia Insulin Network Effort Trial

Navpreet K Bains,Wei Huang,Muhammad ISHFAQ,Brandi R French,Farhan Siddiq,Camilo R Gomez,Adnan I Qureshi

DOI: https://doi.org/10.1161/str.53.suppl_1.wmp3

IF: 10.17

2022-02-01

Stroke

Abstract:Background and Purpose: Hyperglycemia has been associated with higher rates of death or disability in acute ischemic stroke patients undergoing endovascular treatment. However, it remains unclear whether intensive serum glucose reduction can reduce the rates of death or disability in patients undergoing endovascular treatment. Methods: We analyzed the effect of intensive (serum glucose <110 mg/dl) glucose treatment (compared with standard treatment, serum glucose <180 mg/dl) in patients who received endovascular treatment in the Stroke Hyperglycemia Insulin Network Effort (SHINE). We further analyzed the effect of area under the curve of serum glucose, proportion of the time blood glucose was < 140mg/dL, and glucose variability defined as glucose range during 72-hours. The primary outcomes of interest were neurological deterioration within 72 hours and outcome at 90 days. Results: A total of 146 patients (mean age 68.1±13.9, 50.7% were men) underwent endovascular treatment for acute ischemic stroke; 72 and 74 patients were randomized to intensive and standard treatments, respectively. The rates of death (20.3%, and 22.2%), favorable 90-day primary outcome (17.6% and 19.4%), and serious adverse events (41.9% and 56.98%) were similar between the two groups. The area under the curve of serum glucose was not associated with death within 90 days (OR 1, 95% CI 1-1) or favorable outcome at 90 days (OR 1, 95% CI 1-1). Glucose variability was not associated with death or favorable outcome at 90 days. Intensive treatment was not associated with cerebral hemorrhagic events. Conclusion: We did not identify any beneficial effect of intensive glucose reduction on rates of death or favorable outcomes at 90 days among acute ischemic stroke patients undergoing endovascular treatment. We also did not observe any relationship between various glycemic parameters and death or favorable outcomes at 90 days.

peripheral vascular disease,clinical neurology
Hyperglycaemia in Acute Lacunar Stroke: A Chinese Hospital-Based Study

Yuan Fang,Shihong Zhang,Bo Wu,Ming Liu

DOI: https://doi.org/10.1177/1479164112459663

2012-01-01

Abstract:Admission hyperglycaemia is very common in acute ischaemic stroke (IS) patients and is associated with worse outcome in non-lacunar infarction, but its association with lacunar infarction remains controversial. We investigated the association between hyperglycaemia and clinical outcome in patients with acute lacunar stroke in a hospitalised Chinese population. Consecutive patients with acute IS were enrolled and classified into lacunar and non-lacunar stroke groups based on clinical criteria according to the Oxfordshire Community Stroke Project (OCSP) and findings on brain computed tomography (CT) or magnetic resonance imaging (MRI) scan. Hyperglycaemia was defined as blood glucose > 6.1 mmol/L. Univariate and multivariate analyses were used to examine the association between hyperglycaemia and outcomes in diabetic and non-diabetic groups. The main outcome measure was a poor outcome [defined as modified Rankin Scale (mRS) score ≥ 3] at 12 months after stroke. Of the 2020 acute ISs, 689 (34.1%) were acute lacunar strokes, of which 159 (23%) were diabetic and the other 530 (77%) were non-diabetic. In non-lacunar stroke, admission hyperglycaemia was independently associated with increased risk of poor outcome at 1 year (odds ratio (OR) = 1.782; 95% confidence interval (CI) = 1.340–2.370, p = 0.0005). In lacunar stroke, hyperglycaemia was not associated with functional outcome (OR = 1.337; 95% CI = 0.939–1.093, p = 0.086) irrespective of the diabetic status.
EVALUATION OF IMPACT OF HYPERGLYCEMIA AND HYPONATREMIA ON CLINICAL OUT-COME OF ACUTE STROKE

Adnan Iqbal,Rahila Najam,Azfar Athar Ishaqui,Fatima Rehman,Salman Ahmed,Jameela Jamali,Inayatullah Khan,Muhammad Imran,Lailoona Jaweed,Ahmed Muhammad Shaikh,Shayan Ahmed,Zeeshan Ahmed

DOI: https://doi.org/10.38106/lmrj.2023.5.2-04

2023-06-30

Liaquat Medical Research Journal

Abstract:Hyponatremia and hyperglycemia are common metabolic disorders which could worsen the outcome after a cerebrovascular accident (stroke). This study aimed to evaluate the impact of hyponatremia and hyperglycemia on stroke and its clinical outcome, including morbidity and mortality. This prospective cohort study included 50 stroke patients admitted in tertiary care hospitals. Stroke severity, Glasgow coma scale (GCS), conscious level, gag reflex, clinical presentations, and outcomes were recorded. Following a stroke, patients were monitored for a period of six months, during which the patient's death was recorded on the event form. Linear logistic regression model was used to determine the stroke mortality. Hyponatremia and hyperglycaemia were associated with higher odds ratio of deaths, poor functional recovery, severe disability, low mean GCS score as compared to normonatremic and normoglycemic patients (odds ratio [OR] = 4.7; 95% CI= 0.929-43.782) and hyperglycaemia (OR= 2.74; 95% CI=0.577-13.03). Stroke patients admitted with hyperglycemia or hyponatremia were associated with greater morbidity and mortality and poor functional recovery.
Relationship Between Acute Hyperglycemia and Prognosis in Patients Following Spontaneous Intracerebral Hemorrhage

FANG Yuan,YOU Chao,ZHANG Shi-hong,WU bo,TAN Song,ZHANG Di-wen,LIU Ming

DOI: https://doi.org/10.3969/j.issn.1672-5921.2011.04.002

2011-01-01

Abstract:Objectives To investigate the relationship between acute hyperglycemia level and prognosis in patients following spontaneous intracerebral hemorrhage.Methods A total 661 consecutive patients with acute intracerebral hemorrhage(from symptom onset to hospital and evaluated≤24 hours)were admitted to West China Hospital,Sichuan University from March 1,2002 to March 1,2009 were recruited prospectively.The blood glucose levels of the patients and other clinical materials related to the prognosis were collected comprehensively.Hyperglycemia was defined as the blood glucose level≥8 mmol/L at admission. The mortality and disability(as modified Rankin scale≥3)of the patients 1 year after intracerebral hemorrhage were followed up.Multivariate logistic regression was used to analyze the relationship between hyperglycemia and prognosis.Results A total of 661 patients with intracerebral hemorrhage were recruited.①Of the patients,194(29.3%)had hyperglycemia and 65(9.8%)had diabetes mellitus. ②The National Institutes of Health Stroke Scale(NIHSS)score were positively correlated with the admission random blood glucose levels significantly(r =0.392,P =0.000).③Compared to the patients with normal blood glucose,the risk of death in patients with hyperglycemia was 4.357 times of those with normal blood glucose at 1 year(OR =4.357;95% CI:2.586-7.340),and the risks of mortality/disability was 3.117 times of those with normal blood glucose at 1 year(OR =3.117;95% CI:1.888-5.144). Conclusion The blood glucose levels on admission showed significant positive correlation with the severity of the disease.The random glucose level≥8 mmol/L on admission might be an independent risk factor influencing the prognosis of patients 1 year after spontaneous intracerebral hemorrhage.
Use of clinical practice guidelines in managed care physician groups.

E. Fang,Mittman Bs,S. Weingarten

DOI: https://doi.org/10.1001/ARCHFAMI.5.9.528

1996-10-01

Archives of Family Medicine

Abstract:There is increasing interest in the use of clinical guidelines as a tool to improve the quality and cost-effectiveness of health care. Yet, relatively little data are available regarding the use of guidelines by health care provider organizations. We developed a written descriptive survey investigating the development, implementation, and evaluation of clinical guidelines that was administered to medical directors or their designees from physician medical groups and independent practice associations. Eighty-seven percent of physician organizations were reported to be developing or implementing clinical guidelines. The reasons most often cited for developing clinical guidelines were quality improvement and cost containment. Local expert opinion or judgment was rated as the most important influence in the development of clinical guidelines, followed by medical and scientific literature and externally developed guidelines. Feedback of information was the most popular method of increasing compliance with clinical guidelines, although 19% of physician organizations reported imposing sanctions on physicians who did not use guidelines. Most of the physician organizations surveyed have embraced clinical guidelines. Local development or adaptation of clinical guidelines may be common. There has been disproportionately little attention paid to guideline implementation and to evaluation of guideline effects relative to their development.
Association of Admission Glucose and Outcomes After Endovascular Treatment for Acute Stroke: Data From the ANGEL-ACT Registry

Xinyan Wang,Fa Liang,Youxuan Wu,Baixue Jia,Yijun Zhang,Minyu Jian,Haiyang Liu,Anxin Wang,Ruquan Han,Zhongrong Miao

DOI: https://doi.org/10.1097/ANA.0000000000000937

2023-08-25

Abstract:Background: The association between admission glucose levels and clinical outcomes after stroke has not been effectively elucidated. This study assessed the association among admission glucose levels, admission hyperglycemia, diabetes mellitus, and 90-day neurological outcomes in patients with acute ischemic stroke undergoing endovascular therapy. Methods: The ANGEL-ACT registry enrolled adults with acute ischemic stroke undergoing endovascular therapy between 2017 and 2019 in China and patients with available admission glucose data were included. Restricted cubic spline regression was used to determine the knots of blood glucose levels. Binary or ordinal logistic regression models were used to examine the impact of different admission glucose levels on neurological outcomes and 90-day mortality. Results: In total, 1684 participants with available admission glucose concentrations were evaluated. The admission glucose level was divided into 4 levels according to the restricted cubic spline curves: level 1 (<5.3 mmol/L), level 2 (5.3 to 7.0 mmol/L), level 3 (7.0 to 11.6 mmol/L), and level 4 (≥11.6 mmol/L). Level 4 admission glucose was associated with a decreased incidence of a modified Rankin scale score of 0 to 2 (hazard ratio, 0.59; 95% CI, 0.40-0.87) and an increased risk of mortality (hazard ratio, 1.74; 95% CI, 1.06-2.85). Levels 3 and 4, hyperglycemia, and diabetes mellitus independently predicted symptomatic intracranial hemorrhage (sICH). Admission glucose levels showed J-shaped relationships with sICH. Conclusions: Higher admission glucose levels (≥11.6 mmol/L) were associated with a decreased likelihood of a modified Rankin scale score of 0 to 2 and an increased risk of mortality and sICH.
Impact of Relative Blood Glucose Changes on Mortality Risk of Patient with Acute Ischemic Stroke and Treated with Mechanical Thrombectomy.

Ling Wang,Zhiming Zhou,Xiguang Tian,Huaiming Wang,Dong Yang,Yonggang Hao,Zhonghua Shi,Min Lin,Zhen Wang,Dequan Zheng,Mingyi Tu,Wenjie Zi,Gelin Xu,Xinfeng Liu

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.036

2018-01-01

Abstract:BACKGROUND AND PURPOSE:The impacts of stress hyperglycemia and hypoglycemia on mortality of acute ischemic stroke patients treated with mechanical thrombectomy (MT) are largely unclear. This study aimed to use stress hyperglycemia ratio (SHR) to evaluate the influence of pretreatment relative blood glucose changes on mortality risk after MT.METHODS:The study retrospectively enrolled 321 acute ischemic stroke patients treated with MT. SHR was calculated as random blood glucose at admission divided by average blood glucose which estimated by glycosylated hemoglobin (HbA1c). Patients with HbAlc greater than or equal to 6.5% were considered to have background hyperglycemia, patients were tertiled according to their SHR. Binary logistic regression was used to analyze 90 days mortality between SHR categories.RESULTS:Compared with the middle tertiles group (Q2) which the blood glucose is closet to baseline glycaemia, patients in the lowest tertiles group (Q1) and highest tertiles group (Q3) have a higher mortality risk (odds ratio [OR], 3.80; 95% confidence interval [CI], 1.31-11.06) (OR, 3.18; 95% CI, 1.25-8.12), the differences is still significant after further adjusted for admission hyperglycemia (≥11.1 mmol/L). In patients without background hyperglycemia, the mortality risk is significantly higher in Q3 group (OR, 3.01; 95% CI, 1.06-8.53), no significant differences was found between three groups after adjusted for admission hyperglycemia (≥11.1 mmol/L).CONCLUSIONS:SHR identified acute ischemic stroke patients with relative hyperglycemia and hypoglycemia may have higher mortality risk after MT.
Higher Blood Glucose within the Normal Range Is Associated with More Severe Strokes

Rolf J. Martin,Rajiv R. Ratan,Michael J. Reding,Tom S. Olsen

DOI: https://doi.org/10.1155/2012/659610

2012-01-01

Stroke Research and Treatment

Abstract:Background . Higher fasting blood glucose (FBG) concentrations in the hyperglycemic range are associated with more severe strokes. Whether this association also extends into patients with FBG in the normoglycemic range is unclear. We studied the association of stroke severity and FBG in normoglycemic patients with ischemic stroke in a median of 7 days after stroke when the initial glycemic stress response has resolved. Method and Material . Included were 361 nondiabetic ischemic stroke patients with admission fasting blood glucose within 70–130 mg/dL admitted into an acute stroke rehabilitation unit in a median of 7 days after stroke. Data including neuroimaging, vital signs, cardiovascular risk factors, and admission functional independence measure (AFIM) were recorded prospectively. Results . FBG correlated with stroke severity in the normoglycemic 70–130 mg/dL range (FBG-AFIM correlation coefficient − 0.17 ; P = 0.003 ). Odds ratio for more severe injury (below average AFIM score) was 2.02 for patients with FBG 110–130 mg/dL compared to FBG 70–90 mg/dL (95% confidence interval 1.10–3.73, P = 0.022 ). Each mg/dL increase in FBG was associated with an average decrease of 0.25 FIM points. In a multiple linear regression model, FBG was associated with more severe stroke ( P = 0.002 ). Conclusion . One week after ischemic stroke, FBG within the normoglycemic range was associated with stroke severity.

Differential malware forensics

Correlation of Stress Hyperglycemia after Ischemic Stroke with Early Vascular Cognitive Impairment

On the α(u, v)-symmetric implicational method for R- and (S, N)-implications

Management of Hyperglycemia in Acute Ischemic Stroke

[Hyperglycemia: a predictor of poor prognosis in acute stroke]

Persistent Hyperglycemia is a Useful Glycemic Pattern to Predict Stroke Mortality: a Systematic Review and Meta-Analysis

High f/sub T/ 0.05/spl mu/m In/sub 0.52/AlAs/In/sub 0.53/GaAs HEMT's with strained 5 nm InAs sub-channel on InP substrate

Abstract WP3: Serum Glucose Fluctuations is an Independent Predictor of Adverse Outcomes in Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment

Study on the Prognostic Effect of Hyperglycemia in Diabetic and Non-diabetic Patients Treated with Mechanical Thrombectomy

Cell type‐specific epigenome profiling using affinity‐purified nuclei

Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial

[Diagnostics in clinically occult, radiologically suspect breast lesions more often surgery than needle diagnostics with image monitoring].

Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients

Abstract WMP3: Hyperglycemic Control In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: Post-hoc Analysis Of Stroke Hyperglycemia Insulin Network Effort Trial

Hyperglycaemia in Acute Lacunar Stroke: A Chinese Hospital-Based Study

EVALUATION OF IMPACT OF HYPERGLYCEMIA AND HYPONATREMIA ON CLINICAL OUT-COME OF ACUTE STROKE

Relationship Between Acute Hyperglycemia and Prognosis in Patients Following Spontaneous Intracerebral Hemorrhage

Use of clinical practice guidelines in managed care physician groups.

Association of Admission Glucose and Outcomes After Endovascular Treatment for Acute Stroke: Data From the ANGEL-ACT Registry

Impact of Relative Blood Glucose Changes on Mortality Risk of Patient with Acute Ischemic Stroke and Treated with Mechanical Thrombectomy.

Higher Blood Glucose within the Normal Range Is Associated with More Severe Strokes